Fotios (Frank) Michelis

Fotios (Frank) Michelis, MD, PhD

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Keywords: immune reconstitution, late effects, acute myeloid leukemia (AML), allogeneic stem cell/bone marrow transplant

Impact of comorbidities constituting the HCT-CI score on the outcome of patients undergoing allogeneic HCT for AML.
Eur J Haematol. 2017 Nov 23;:
Khalil MMI, Lipton JH, Atenafu EG, Gupta V, Kim DD, Kuruvilla J, Viswabandya A, Messner HA, Michelis FV
Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1.
Eur J Haematol. 2017 May 27;:
Bourlon C, Lipton JH, Deotare U, Gupta V, Kim DD, Kuruvilla J, Viswabandya A, Thyagu S, Messner HA, Michelis FV
Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data.
Eur J Haematol. 2017 Apr 27;:
Poch Martell M, Hamad N, Shin E, Moon JH, Sohn SK, Uhm J, Michelis FV, Viswabandya A, Lipton JH, Messner HA, Kim DDH
Progressive multifocal leukoencephalopathy due to John Cunningham (JC) virus following allogeneic hematopoietic cell transplantation.
Antivir Ther. 2017 Mar 31;:
Lam W, Al-Shaibani Z, Kumar D, Viswabandya A, Thyagu S, Michelis FV, Dennis (Dong-Hwon) Kim, Lipton JH, Messner HA, Deotare U
Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Biol Blood Marrow Transplant. 2017 Jun;23(6):945-951
Michelis FV, Kotchetkov R, Grunwald RM, Azeem A, Atenafu EG, Lipton JH, Loach D, Gupta V, Kuruvilla J, Kim DD, Viswabandya A, Deotare U, Messner HA
A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient.
Bone Marrow Transplant. 2017 Jun;52(6):907-909
Bourlon C, Alamoudi S, Kumar D, Viswabandya A, Thyagu S, Michelis FV, Kim DD, Lipton JH, Messner HA, Deotare U
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
Cancer. 2017 Jun 01;123(11):2035-2042
Michelis FV, Gupta V, Zhang MJ, Wang HL, Aljurf M, Bacher U, Beitinjaneh A, Chen YB, DeFilipp Z, Gale RP, Kebriaei P, Kharfan-Dabaja M, Lazarus HM, Nishihori T, Olsson RF, Oran B, Rashidi A, Rizzieri DA, Tallman MS, de Lima M, Khoury HJ, Sandmaier BM,...
Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched Analysis.
Biol Blood Marrow Transplant. 2016 Dec;22(12):2270-2275
Sibai H, Falcone U, Deotare U, Michelis FV, Uhm J, Gupta V, Kuruvilla J, Lipton JH, Seftel MD, Messner HA, Kim DD
A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient.
Bone Marrow Transplant. 2016 Oct;51(10):1385-1386
Lam W, Viswabandya A, Hussain S, Messner HA, Michelis FV, Kim DD, Lipton JH, Deotare U
Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study.
Bone Marrow Transplant. 2016 Jul;51(7):1019-21
Michelis FV, Atenafu EG, Couban S, Frazer J, Shivakumar S, Hogge DE, Toze CL, Rajkhan W, Kim HJ, Daly A, Slaby J, Finke J, Kiss T, Bredeson C, Sabloff M, Sheppard D, Bakkar M, Brune M, Wall DA, Paulson K, Popradi G, Walker I, Messner HA

Pages
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Assistant Professor, Department of Medicine, University of Toronto